Marketed Products

FIRDAPSE ®

(amifampridine phosphate)

FIRDAPSE (amifampridine) is indicated for the symptomatic treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) in adults. FIRDAPSE should only be prescribed by health professionals who have experience in the treatment of LEMS, are knowledgeable of the efficacy and safety profile of this drug, and are able to discuss benefits/risks of treatment with patients.

FIRDAPSE Patient Support Program Enrollment Form

Product Monograph

FIRDAPSE Patient Support Program Enrollment Form

Product Monograph